Health Headlines: How your age affects healthcare screenings
In today’s health headlines, how your age affects the kind of healthcare and screenings your doctor recommends as you get older. Radiation oncologist at Yale Cancer Center and Smilow Cancer Hospital, and Professor of Therapeutic Radiology at Yale School of Medicine, Dr. Suzanne Evans, is discussing this topic.Source: WTNH
Gap Discovered in Breast Cancer Radiotherapy Recommendations for Patients Aged 70 vs 69 Years
Age-based heuristics may lead to large differences in breast cancer treatment based on small differences in chronologic age, according to a new study published by Talcott et al in the International Journal of Radiation Oncology, Biology, and Physics.Source: The ASCO Post
Fighting Breast and Ovarian Cancer With a Lupus Antibody
After discovering a specific lupus antibody that can penetrate cancer cells and, with a grant from Women's Health Research at Yale, showing it makes cancer cells vulnerable to standard treatments, Dr. Peter Glazer and his colleagues are moving a treatment to clinical trials.
Positively Pink: Technology Making Mammogram Callbacks Less Frequent
Doctors at the Smilow Cancer Hospital Care Center in Waterford look at family and medical history as well as mammogram images when women get their annual screenings. Sometimes doctors spot an area that looks abnormal.Source: WTNH News 8
Smilow Shares Fairfield and Trumbull to Host Virtual Sessions on Breast Cancer Awareness and Treatment Advances
Smilow Cancer Hospital Care Centers in Fairfield and Trumbull will be hosting a virtual Smilow Shares program on “Breast Cancer Awareness and Treatment Advances” on Tuesday, October 21 at 7pm.
Smilow Shares Waterford and Westerly to Host Virtual Sessions on Breast Cancer Awareness and Treatment Advances
Smilow Cancer Hospital Care Centers in Waterford and Westerly will be hosting a virtual Smilow Shares program on “Breast Cancer Awareness and Treatment Advances” on Tuesday, October 28 at 7pm.
Breast Cancer Treatments Less ‘Radical,’ More Effective than Ever, Doctors Say
It’s been years, even decades since breast cancer was considered a death sentence, and advancements occurring at virtually every stage of its detection and treatment frequently generate more welcome news.Source: The Day
Better Science, Better Lives: Women's Health Research at Yale is Working for You
Across the country, it’s becoming clearer every day: We must study the health of women. We must study the influence of sex-and-gender differences on health. And it’s time for all aspects of medical research and practice to embrace this change.
Yale Study Identifies How Cancer Drug Inhibits DNA Repair in Cancer Cells
Yale Cancer Center researchers have found that a cancer drug thought to be of limited use possesses an unforeseen property. It is able to stop certain cancer cells from repairing their DNA in order to survive. The study suggests that combining this drug, cediranib, with other agents could potentially deliver a lethal blow in cancer that uses a specific process to create DNA repair cells.
New Study in JNCCN Calls for Continued Aggressive Treatment for Breast Cancer in Women Under 40
A new study from the Stanford Cancer Institute finds that young women who are treated with chemotherapy for breast cancer but have residual tumor in either the breast or lymph nodes have higher chances of recurrence compared to those with no evidence of any residual invasive tumor (pathologic complete response). “By assessing patient outcomes in a relatively large group of women under 40 treated with neoadjuvant chemotherapy, this study adds significantly to the existing literature,” said Meena S. Moran, MD, Professor and Director of Yale Radiation Therapy Breast Program, Yale Cancer Center/Smilow Cancer Hospital, Member, NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Panel for Breast Cancer.Source: JNCCN